These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 10774946)

  • 21. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
    Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M
    Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci.
    Rodolico C; Toscano A; Patitucci A; Muglia M; Gaeta M; D'Arrigo G; Migliorato A; Messina S; Quattrone A; Messina C; Vita G
    Neurol Sci; 2005 Dec; 26(5):303-9. PubMed ID: 16388363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-fiber electromyography in sporadic inclusion body myopathy.
    Hatanaka Y; Oh SJ
    Clin Neurophysiol; 2007 Jul; 118(7):1563-8. PubMed ID: 17507289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology.
    Fidziańska A; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
    Acta Neuropathol; 2004 Mar; 107(3):197-203. PubMed ID: 14712398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical and myopathological features of oculopharyngodistal myopathy in a Chinese family.
    Lu H; Luan X; Yuan Y; Dong M; Sun W; Yan C
    Neuropathology; 2008 Dec; 28(6):599-603. PubMed ID: 18503509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
    Dalakas MC
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes.
    Mastaglia F; Price P; Walters S; Fabian V; Miller J; Zilko P
    Neuromuscul Disord; 2006 Nov; 16(11):754-8. PubMed ID: 16934978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis.
    Cox FM; Reijnierse M; van Rijswijk CS; Wintzen AR; Verschuuren JJ; Badrising UA
    Rheumatology (Oxford); 2011 Jun; 50(6):1153-61. PubMed ID: 21288962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy.
    Goebel HH; Halbig LE; Goldfarb L; Schober R; Albani M; Neuen-Jacob E; Voit T
    Neuropediatrics; 2001 Aug; 32(4):196-205. PubMed ID: 11571700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects.
    Engel WK; Askanas V
    Neurology; 2006 Jan; 66(2 Suppl 1):S20-9. PubMed ID: 16432141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised troponin T in inclusion body myositis is common and serum levels are persistent over time.
    Lindberg C; Klintberg L; Oldfors A
    Neuromuscul Disord; 2006 Aug; 16(8):495-7. PubMed ID: 16920359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
    Greenberg SA; Pinkus JL; Amato AA
    Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients.
    Santorelli FM; Sciacco M; Tanji K; Shanske S; Vu TH; Golzi V; Griggs RC; Mendell JR; Hays AP; Bertorini TE; Pestronk A; Bonilla E; DiMauro S
    Ann Neurol; 1996 Jun; 39(6):789-95. PubMed ID: 8651651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term observational study of sporadic inclusion body myositis.
    Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
    Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of inclusion body myositis.
    Cherin P
    Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital myopathy with tubular aggregates and tubulofilamentous IBM-type inclusions.
    Fidziańska A; Kamińska A; Ryniewicz B
    Neuropediatrics; 2005 Feb; 36(1):35-9. PubMed ID: 15776320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
    Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
    Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
    Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
    Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.